Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-30 08:52:05 - browse：6

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Why getting cancer drugs just got harder for rural patients

explore

WSS

Biotech companies concerned about China biosecurity crackdown

Why Talkspace is targeting Medicare, a tricky market

Obesity now affects over 1 billion people worldwide, study finds

Fetal cell organoids grown from amniotic fluid, study finds

Stem cell biologist probes earliest stages of human development

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

hotspot

Wikipedia

focus

The high cost of giving birth even with insurance

RSV vaccines may be linked to small increased risk of developing GBS

United colonoscopy coverage change 'may cost lives,' doctors say

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

As demand for Covid shots wanes, Moderna seeks its next success

The untold story of TV’s first prescription drug ad

How to save PrEP access — and even expand it

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Hepatitis C has a cure — but many Americans still lack access to it

Longer MASH drug regimen improved liver, Akero study finds

focus

Families look for replacement for GSK asthma drug Flovent

Why getting cancer drugs just got harder for rural patients

Kenai launches with $82 million for Parkinson’s stem cell therapy

Readout Newsletter: BridgeBio, Akero, and human embryo models

Clinical trials giant ICON acquires HumanFirst

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

hotspot

entertainment

explore

focus